EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Feasibility and Preliminary Effects of Acupuncture for Cognitive Dysfunction in Diverse Cancer Survivors: A Pilot, Randomized, Placebo-Controlled Trial

Xiaotong Li, Kaitlin Lampson iD, Tim A Ahles, James C Root, Q Susan Li, Yuelin Li, Anam Ahsan, Jun J Mao, Kevin T Liou iD

Current Oncology · 01.01.2025 · 32 (1) · 27

DOI: 10.3390/curroncol32010027 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Current Oncology, online erschienen am 01.01.2025. Verfasst von Xiaotong Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Hauptthemen laut MEDLINE: Acupuncture Therapy, Cancer Survivors, Cognitive Dysfunction, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, Memorial Sloan Kettering Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

This pilot study evaluates the feasibility and preliminary effects of acupuncture for cancer-related cognitive dysfunction (CRCD) in cancer survivors. (2)

Methods

A randomized trial comparing real acupuncture (RA) to sham acupuncture (SA) and waitlist control (WLC) among cancer survivors reporting cognitive difficulties. Interventions were delivered weekly over 10 weeks. Feasibility was evaluated by recruitment, treatment adherence, and assessment completion. Subjective CRCD was assessed by the Functional Assessment of Cancer Therapy-Cognitive Function—Perceived Cognitive Impairment subscale (FACT-Cog PCI) and objective CRCD was assessed by the Hopkins Verbal Learning Test—Revised (HVLT-R). (3)

Results

32 participants (57.1% of eligible patients) were enrolled. All participants in acupuncture groups completed ≥8 of 10 treatments. Assessment completion rate was 100% for all participants. From baseline to week 10, the RA group (n = 19) reported a clinically meaningful 17.3-point increase in FACT-Cog PCI (95% confidence interval [CI] 12.5 to 22.1), compared to 9.7 points (95% CI 2.8 to 16.7) in the SA group (n = 9), and 6.8 points (95% CI −3.7 to 17.2) in the WLC group (n = 4). In the subgroup analysis among patients with a below-average baseline HVLT-R (T-score < 50), the RA group (n = 8) increased FACT-Cog PCI scores by 20.4 (95% CI 13.6 to 27.3), compared to 11.1 points (95% CI 0.6 to 21.5) in the SA group (n = 5). The improvements from RA persisted through week 16 in both the total sample and the sub-group. Eleven mild adverse events were reported, with pain and bleeding at the needling sites being the most common. (4)

Conclusions

The findings support the feasibility and safety of conducting a randomized, placebo-controlled trial to evaluate acupuncture for cognitive dysfunction in cancer survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acupuncture TherapyCancer SurvivorsCognitive DysfunctionNeoplasmsHumansPilot ProjectsMaleFemaleMiddle AgedFeasibility StudiesAgedAdult

Stichwörter der Autor:innen

acupuncturecancer survivorshipcognitive dysfunctionfeasibilitypilot study

Autor:innen und Institutionen

  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

ORCID-Profile: Kaitlin Lampson, Kevin T Liou

Förderung

  • NCI NIH HHS
  • NIH HHS
  • Memorial Sloan Kettering Cancer Center
  • MSK’s Integrative Medicine and Translational Research Fund and in part by an NIH/NCI Cancer Center Support Grant
  • National Cancer Institute’s Mentored Clinical Scientist Research Career Development Award

Zitieren

APA

Li, X., Lampson, K., Ahles, T. A., Root, J. C., Li, Q. S., Li, Y., Ahsan, A., Mao, J. J., & Liou, K. T. (2025). Feasibility and Preliminary Effects of Acupuncture for Cognitive Dysfunction in Diverse Cancer Survivors: A Pilot, Randomized, Placebo-Controlled Trial. Current Oncology, 32(1), 27. https://doi.org/10.3390/curroncol32010027

Vancouver

Li X, Lampson K, Ahles TA, Root JC, Li QS, Li Y, et al. Feasibility and Preliminary Effects of Acupuncture for Cognitive Dysfunction in Diverse Cancer Survivors: A Pilot, Randomized, Placebo-Controlled Trial. Current Oncology. 2025;32(1):27. doi:10.3390/curroncol32010027

BibTeX
@article{Li2025,
  author = {Li, Xiaotong and Lampson, Kaitlin and Ahles, Tim A and Root, James C and Li, Q Susan and Li, Yuelin and Ahsan, Anam and Mao, Jun J and Liou, Kevin T},
  title = {Feasibility and Preliminary Effects of Acupuncture for Cognitive Dysfunction in Diverse Cancer Survivors: A Pilot, Randomized, Placebo-Controlled Trial},
  journal = {Current Oncology},
  year = {2025},
  volume = {32},
  number = {1},
  pages = {27},
  doi = {10.3390/curroncol32010027}
}
Kostenlos starten →